SCHEMBL13574116

SCHEMBL13574116

Bc1cc(Cl)c2nc(Nc3cc(CN4CCN(C)CC4)cc(-c4cnn(C)c4)c3)ncc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 13/20 0.42
▸ FGFR1 P11362 2/20 0.41
▸ MAP4K3 Q8IVH8 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ AURKB Q96GD4 1/20 0.40
▸ WNT1 P04628 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ FGFR4 P22455 2/20 0.38
▸ TTK P33981 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ CCNT1 O60563 1/20 0.37
▸ CCNB2 O95067 1/20 0.37
▸ CCNE2 O96020 1/20 0.37
▸ CDK1 P06493 1/20 0.37
▸ CCNB1 P14635 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CDK9 P50750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13574038 0.93 TYRO3 (0.41) AXLMAP4K3MAP4K1WNT1GSK3B
SCHEMBL13362824 0.90 AXL (0.42) AXLFGFR1MAP4K3MAP4K1AURKB
SCHEMBL13336230 0.90 AXL (0.42) AXLFGFR1MAP4K3MAP4K1AURKA
SCHEMBL13336131 0.83 TYRO3 (0.41) AXLMAP4K3MAP4K1WNT1GSK3B
SCHEMBL13574026 0.83 GSK3B (0.43) AXLMAP4K3MAP4K1WNT1GSK3B
SCHEMBL13336218 0.81 TYRO3 (0.39) AXLFGFR1MAP4K3MAP4K1WNT1
SCHEMBL13336250 0.79 SYK (0.42) AXLFGFR1AURKAAURKBWNT1
SCHEMBL13362896 0.77 MAP4K1 (0.43) MAP4K3MAP4K1WNT1GSK3BDYRK1A
SCHEMBL13335984 0.75 MAP4K1 (0.45) AXLFGFR1MAP4K3MAP4K1WNT1
SCHEMBL13574022 0.75 GSK3B (0.44) AXLMAP4K3MAP4K1WNT1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009153313-A1 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2009-12-23 — — WO disclosed
Send feedback